Steroid-sparing therapy important in pandemic, SECURE-IBD registry shows

Findings from the SECURE-IBD registry confirm many of the observed risk factors for severe COVID-19 disease in the general population apply to patients with Crohn’s disease and ulcerative colitis. The data from 528 mostly white patients from 33 countries, published in Gastroenterology, showed older age, two or more comorbidities, and systemic corticosteroid use were associated ...

Already a member?

Login to keep reading.

© 2021 the limbic